Get the Stockscreener App
1.94
6.28%
-0.13
Silo Pharma Inc stock is traded at $1.94, with a volume of 40,133.
It is down -6.28% in the last 24 hours and down -39.38% over the past month.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
See More
Previous Close:
$2.07
Open:
$2.09
24h Volume:
40,133
Relative Volume:
0.22
Market Cap:
$3.40M
Revenue:
$72,100
Net Income/Loss:
$-4.84M
P/E Ratio:
-0.2602
EPS:
-7.4566
Net Cash Flow:
$-3.84M
1W Performance:
-14.91%
1M Performance:
-39.38%
6M Performance:
-59.88%
1Y Performance:
-83.85%
1-Day Range:
$1.91
$2.09
1-Week Range:
$1.91
$2.39
52-Week Range:
$1.91
$15.15
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma Inc
Sector
Industry
Phone
(718) 400-9031
Address
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO vs MOBBW, PSNYW, GOODO, SHMD, CHAD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
1.20 | 2.19B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
4.68 | 663.69M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
20.07 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.20 | 222.94M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
8.29 | 197.39M | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Stock (SILO) Latest News
SpaceX Stock Price Today | SPCX Ticker, News, Retail Sentiment - Stocktwits
Silo Pharma Inc (NYSE: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma Highlights Patented Nose-To-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum - marketscreener.com
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15 - citybuzz -
Silo Pharma to Participate in IPAC-RS 2026 Nasal Innovation Forum as It Advances SPC-15 Development - Quiver Quantitative
A nasal PTSD treatment met specs for nine months - Stock Titan
Silo Pharma Stock Price Forecast. Should You Buy SILO? - StockInvest.us
Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma Inc (SILO) Peer Comparison – Compare with Others - Value Research
Silo Pharma Inc (SILO) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Silo Pharma Acquires Digital Assets via Stock Issuance - The Globe and Mail
Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com South Africa
Form 8K Silo Pharma Inc For: 19 August - Investing.com India
Silo Pharma Acquires Software and IP From Parkview Consulting for 165,000 Shares - TradingView
Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting - TradingView
Silo PharmaEnters Asset Purchase Agreement - Moomoo
Silo Pharma receives Canadian patent allowance for SPC-15 drug By Investing.com - Investing.com Canada
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - manilatimes.net
Silo Pharma Receives Notice of Allowance for Canadian Patent Application Covering Lead Asset Spc-15 Targeting Ptsd and Other Stress-Induced Psychiatric Disorders - marketscreener.com
Silo (SILO) Technical Check: Adds 1.95% to Close at $3.13; Range and Risk: the $2.97 to $3.29 Range Remains in Focus in the Current UpdateSuperTrend - Vinanet
Silo Pharma Shareholders Approve Major Share Authorization Expansion - TipRanks
Silo Pharma (SILO) holders approve lifting share cap from 6.7M - Stock Titan
Silo Pharma (SILO) Slips 0.62% to $3.20 as Shares Consolidate Between Key Technical LevelsStock Picks - Vinanet
Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - Stock Titan
Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa
Silo Pharma Granted European Patent Covering Novel PTSD Therapy - The Manila Times
Silo Pharma receives European patent for SPC-15 PTSD treatment - Investing.com India
Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver Quantitative
SILO Q4 2023 Earnings: Wider-than-Expected Loss of -$5.40 per Share Highlights Heavy Pre-Revenue InvestmentTax Rate Impact - vinanet.vn
Silo Pharma Inc (SILO) Stock News Today - TradingKey
SILO Forecast & Price Target - TradingKey
Silo Pharma, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Silo Pharma (SILO) Q4 2023 Earnings: Wider-Than-Expected Loss Sends Shares Down 20%Quarterly Earnings - vinanet.vn
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform - marketscreener.com
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon - GlobeNewswire
SILO|Silo Pharma Inc|Price:3.200|Chg%:-0.020 - TradingKey
SILO Q4 2023 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage R&D SpendingQuarterly Earnings Report - vinanet.vn
Silo Pharma, Inc. Revenue Breakdown – NASDAQ:SILO - TradingView
Silo Pharma Inc (SILO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Silo Pharma Inc. Q4 2023 Earnings: Wider-Than-Expected Loss Weighs on SharesHigh Estimate Range - vinanet.vn
Silo Pharma Inc (SILO) Income Statement - TradingKey
SILO|Silo Pharma Inc|Price:4.470|Chg%:+0.010 - TradingKey
Silo Pharma Inc (SILO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Silo Pharma Inc (SILO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Silo Pharma Inc (SILO) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Form S-3 Silo Pharma Inc For: 24 July By Investing.com - Investing.com India
Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common StockSEC Filing - TradingView
SILO Q4 2023 Earnings: Significant EPS Miss Highlights Operational ChallengesEarnings Volatility Report - vinanet.vn
Silo Pharma Inc Stock (SILO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Silo Pharma Inc Stock (SILO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.37 |
1,000 |
370 |
210,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.36 |
1,000 |
365 |
211,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 18 '25 |
Buy |
0.40 |
7,500 |
3,025 |
205,432 |
| Weisblum Eric | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.41 |
4,500 |
1,823 |
209,932 |
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):